Skip to main content

Find Clinical Trials

Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

73 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Infliximab in Treating Patients With Myelodysplastic Syndrome

NCT00074074

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations: AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View all 19 locations

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

NCT00003662

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +16 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Division of Pediatric Surgery Jacksonville, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States

View all 15 locations

View Trial Details

Completed

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00055653

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +44 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 25 locations

View Trial Details

Completed

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

NCT00002809

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

NCT00003336

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +15 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome

NCT00024050

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +6 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

NCT00003913

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 23 locations

View Trial Details

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00027924

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00005853

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +7 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details